A new test-of-concept study suggests that using personalized combination therapy could improve the outcome for people with stubborn metastatic cancer.
from Medical Innovation News From Medical News Today http://bit.ly/2IQVaDb
from Medical Innovation News From Medical News Today http://bit.ly/2IQVaDb